Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Catheters pulled from market | Updated HF guidelines | A key FDA approval | ACHD programs | New imaging systems | Heartflow data
Monday, August 31, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Boston Scientific removes imaging catheters from market due to risk of injury

The issue, brought on by a manufacturing defect, has been linked to two serious injuries. The FDA shared an early alert about the situation as it continues its investigation. 

READ MORE >
The U.S. Food and Drug Administration (FDA) is warning the public about an ongoing safety issue with certain intravascular catheters manufactured by Boston Scientific. These devices are being removed from the market, and Boston Scientific has officially decided to discontinue them going forward. The devices in question are Boston Scientific’s single-use Imager II Angiographic Catheters, which interventional cardiologists, vascular surgeons and interventional radiologists.
Share on Twitter Share on Facebook Share on Linkedin

Boston Scientific removes imaging catheters from market due to risk of injury

Share on Twitter Share on Facebook Share on Linkedin
The U.S. Food and Drug Administration (FDA) is warning the public about an ongoing safety issue with certain intravascular catheters manufactured by Boston Scientific. These devices are being removed from the market, and Boston Scientific has officially decided to discontinue them going forward. The devices in question are Boston Scientific’s single-use Imager II Angiographic Catheters, which interventional cardiologists, vascular surgeons and interventional radiologists.
The issue, brought on by a manufacturing defect, has been linked to two serious injuries. The FDA shared an early alert about the situation as it continues its investigation. 
READ MORE >

New ESC heart failure guidelines include major updates

The new guidelines, published in European Heart Journal and presented at ESC Congress 2026, show just how much heart failure care has evolved in recent years.

READ MORE >
The European Society of Cardiology (ESC) Congress 2023 meeting. Photo by Dave Fornell
Share on Twitter Share on Facebook Share on Linkedin

New ESC heart failure guidelines include major updates

Share on Twitter Share on Facebook Share on Linkedin
The European Society of Cardiology (ESC) Congress 2023 meeting. Photo by Dave Fornell
The new guidelines, published in European Heart Journal and presented at ESC Congress 2026, show just how much heart failure care has evolved in recent years.
READ MORE >

FDA approves tirzepatide for reducing cardiovascular risk in adults with type 2 diabetes

The popular diabetes drug, sold by Eli Lilly and Company under the brand name Mounjaro, has been at the center of many cardiology trials over the years. It is the first dual GIP and GLP-1 hormone receptor agonist approved by the FDA for this indication.

READ MORE >
Tirzepatide, a once-weekly injectable dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide receptor agonist (GLP-1), has been approved by the U.S. Food & Drug Administration (FDA) for improving glycemic control among adults with type 2 diabetes. The medication, sold by Eli Lilly and Company under the name Mounjaro, will be available in six different doses and come in an auto-injector pen.
Share on Twitter Share on Facebook Share on Linkedin

FDA approves tirzepatide for reducing cardiovascular risk in adults with type 2 diabetes

Share on Twitter Share on Facebook Share on Linkedin
Tirzepatide, a once-weekly injectable dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide receptor agonist (GLP-1), has been approved by the U.S. Food & Drug Administration (FDA) for improving glycemic control among adults with type 2 diabetes. The medication, sold by Eli Lilly and Company under the name Mounjaro, will be available in six different doses and come in an auto-injector pen.
The popular diabetes drug, sold by Eli Lilly and Company under the brand name Mounjaro, has been at the center of many cardiology trials over the years. It is the first dual GIP and GLP-1 hormone receptor agonist approved by the FDA for this indication.
READ MORE >

Adult congenital heart programs growing more important as time goes on

More than 95% of congenital heart patients now survive into adulthood, leaving clinicians with much more ground to cover than ever before. Providing high-quality care for these patients requires specialty care as well as collaborations with general cardiologists.

READ MORE >
Dan Halpern, MD, director of the NYU adult congenital heart program, and Klinsky Family associate professor off cardiology at NYU Langone, explains how his adult congenital heart program works and how referrals are helping guide care for these complex patients. He said the number of adult con genital patients is increasing due to the high survival outcomes from interventions earlier in a patients life.
Share on Twitter Share on Facebook Share on Linkedin

Adult congenital heart programs growing more important as time goes on

Share on Twitter Share on Facebook Share on Linkedin
Dan Halpern, MD, director of the NYU adult congenital heart program, and Klinsky Family associate professor off cardiology at NYU Langone, explains how his adult congenital heart program works and how referrals are helping guide care for these complex patients. He said the number of adult con genital patients is increasing due to the high survival outcomes from interventions earlier in a patients life.
More than 95% of congenital heart patients now survive into adulthood, leaving clinicians with much more ground to cover than ever before. Providing high-quality care for these patients requires specialty care as well as collaborations with general cardiologists.
READ MORE >

GE HealthCare announces 3 new ultrasound imaging systems

Each system is powered by GE HealthCare's cSound imaging architecture and includes advanced AI capabilities.

READ MORE >
GE HealthCare has unveiled three major new additions to its Vivid cardiovascular ultrasound portfolio: Vivid Explorer, Vivid Advanced and Vivid Focus.
Share on Twitter Share on Facebook Share on Linkedin

GE HealthCare announces 3 new ultrasound imaging systems

Share on Twitter Share on Facebook Share on Linkedin
GE HealthCare has unveiled three major new additions to its Vivid cardiovascular ultrasound portfolio: Vivid Explorer, Vivid Advanced and Vivid Focus.
Each system is powered by GE HealthCare's cSound imaging architecture and includes advanced AI capabilities.
READ MORE >

Heartflow tech limits unnecessary catheterizations in patients with suspected CAD

AI-powered software from Heartflow can provide cath labs with a lot of value, according to new late-breaking data presented at ESC Congress 2026.

READ MORE >
HeartFlow CCTA FFRct being read by Quantum radiologist Demetrius Dicks, MD, in Marietta, Georgia.
Share on Twitter Share on Facebook Share on Linkedin

Heartflow tech limits unnecessary catheterizations in patients with suspected CAD

Share on Twitter Share on Facebook Share on Linkedin
HeartFlow CCTA FFRct being read by Quantum radiologist Demetrius Dicks, MD, in Marietta, Georgia.
AI-powered software from Heartflow can provide cath labs with a lot of value, according to new late-breaking data presented at ESC Congress 2026.
READ MORE >

Featured Articles

PAD significantly increases risk of AFib, new meta-analysis confirms

Clinicians may want to take a more proactive approach when managing PAD patients to ensure they minimize the risk of new-onset atrial fibrillation. 

READ MORE >
doctor patient elderly check up hospital
Share on Twitter Share on Facebook Share on Linkedin

PAD significantly increases risk of AFib, new meta-analysis confirms

Share on Twitter Share on Facebook Share on Linkedin
doctor patient elderly check up hospital
Clinicians may want to take a more proactive approach when managing PAD patients to ensure they minimize the risk of new-onset atrial fibrillation. 
READ MORE >

Cath lab procedure kits recalled due to ongoing safety concern

The manifolds inside these kits have been linked to a significant risk of contamination.

READ MORE >
Product Recall
Share on Twitter Share on Facebook Share on Linkedin

Cath lab procedure kits recalled due to ongoing safety concern

Share on Twitter Share on Facebook Share on Linkedin
Product Recall
The manifolds inside these kits have been linked to a significant risk of contamination.
READ MORE >

SCAI asks ABIM to rethink policy on PCI volume reporting requirements

Procedural volume reporting requirements for PCI are no longer necessary, according to SCAI and its members. Those requirements made sense when PCI was new, but that was many years ago. 

READ MORE >
Simpsons Interventions, a California-based healthcare technology company, has received the FDA’s breakthrough device designation for its Acolyte Image Guided Crossing and Re-Entry Catheter System. SCAI released the list of its late-breaking clinical study trials at its 2022 annual meeting. #SCAI #SCAI22 #SCAI2022
Share on Twitter Share on Facebook Share on Linkedin

SCAI asks ABIM to rethink policy on PCI volume reporting requirements

Share on Twitter Share on Facebook Share on Linkedin
Simpsons Interventions, a California-based healthcare technology company, has received the FDA’s breakthrough device designation for its Acolyte Image Guided Crossing and Re-Entry Catheter System. SCAI released the list of its late-breaking clinical study trials at its 2022 annual meeting. #SCAI #SCAI22 #SCAI2022
Procedural volume reporting requirements for PCI are no longer necessary, according to SCAI and its members. Those requirements made sense when PCI was new, but that was many years ago. 
READ MORE >

No significant sex-based differences in timing of care for M-TEER patients

Previous studies over the years have suggested women with severe mitral regurgitation face longer delays in care than men. This latest analysis suggests multidisciplinary care teams are helping put an end to that trend.

READ MORE >
cardiologist viewing heart data
Share on Twitter Share on Facebook Share on Linkedin

No significant sex-based differences in timing of care for M-TEER patients

Share on Twitter Share on Facebook Share on Linkedin
cardiologist viewing heart data
Previous studies over the years have suggested women with severe mitral regurgitation face longer delays in care than men. This latest analysis suggests multidisciplinary care teams are helping put an end to that trend.
READ MORE >

In Case You Missed It

The burnout crisis among cardiac CT specialists is getting worse

Six in 10 cardiovascular imagers report feelings of burnout, and many of them are thinking about leaving the field altogether. 

READ MORE >
Kavitha Chinnaiyan, MD, immediate past-president of the SCCT, and a professor of medicine at Corewell Health William Beaumont University Hospital, Royal Oak, Michigan, explains how to prevent workforce burnout and promote well-being in cardiac CT. #SCCT #SCCT2026 #YesCCT
Share on Twitter Share on Facebook Share on Linkedin

The burnout crisis among cardiac CT specialists is getting worse

Share on Twitter Share on Facebook Share on Linkedin
Kavitha Chinnaiyan, MD, immediate past-president of the SCCT, and a professor of medicine at Corewell Health William Beaumont University Hospital, Royal Oak, Michigan, explains how to prevent workforce burnout and promote well-being in cardiac CT. #SCCT #SCCT2026 #YesCCT
Six in 10 cardiovascular imagers report feelings of burnout, and many of them are thinking about leaving the field altogether. 
READ MORE >

Shared cardiac PET programs can expand access while controlling costs

Access to cardiac PET remains limited, but working together with radiology departments is one way to overcome the significant capital investment.

READ MORE >
Nicole Knight from MedAxiom discusses building a sustainable business case for shared cardiac PET imaging. #CVNuc #ThinkPET @MyASNC
Share on Twitter Share on Facebook Share on Linkedin

Shared cardiac PET programs can expand access while controlling costs

Share on Twitter Share on Facebook Share on Linkedin
Nicole Knight from MedAxiom discusses building a sustainable business case for shared cardiac PET imaging. #CVNuc #ThinkPET @MyASNC
Access to cardiac PET remains limited, but working together with radiology departments is one way to overcome the significant capital investment.
READ MORE >

Heart experts fear Trump’s FDA is ‘ignoring decades of evidence’ as it authorizes new nicotine pouches

The FDA has authorized four new flavored nicotine pouches, highlighting their potential to help adults stop smoking cigarettes. The American Heart Association shared its concerns with the move, saying "key questions" remain unanswered.

READ MORE >
FDA authorizes nicotine pouch
Share on Twitter Share on Facebook Share on Linkedin

Heart experts fear Trump’s FDA is ‘ignoring decades of evidence’ as it authorizes new nicotine pouches

Share on Twitter Share on Facebook Share on Linkedin
FDA authorizes nicotine pouch
The FDA has authorized four new flavored nicotine pouches, highlighting their potential to help adults stop smoking cigarettes. The American Heart Association shared its concerns with the move, saying "key questions" remain unanswered.
READ MORE >

In Other News

Department experiments with adding ‘like’ button into radiology reporting workflows

Diagnostic radiologists rarely receive routine feedback from referring clinicians on the quality and value of their work, likely contributing to burnout and poor job satisfaction, experts write. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Department experiments with adding ‘like’ button into radiology reporting workflows

Share on Twitter Share on Facebook Share on Linkedin
Diagnostic radiologists rarely receive routine feedback from referring clinicians on the quality and value of their work, likely contributing to burnout and poor job satisfaction, experts write. 
READ MORE >

When Bill Gates talks world-changing technology, people listen. Have you heard what he’s saying about AI in healthcare?

“Bill Gates warns ‘there is no plan’ for the ‘upheaval’ AI will cause.” … “Bill Gates says AI will either be ‘greatest equalizer’ or ‘worst source of injustice’” … “Bill Gates is deeply worried about AI—and he’s no longer staying quiet” ...  

READ MORE >
bill gates
Share on Twitter Share on Facebook Share on Linkedin

When Bill Gates talks world-changing technology, people listen. Have you heard what he’s saying about AI in healthcare?

Share on Twitter Share on Facebook Share on Linkedin
bill gates
“Bill Gates warns ‘there is no plan’ for the ‘upheaval’ AI will cause.” … “Bill Gates says AI will either be ‘greatest equalizer’ or ‘worst source of injustice’” … “Bill Gates is deeply worried about AI—and he’s no longer staying quiet” ...  
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup